Related Experiment Video
Updated: Apr 28, 2026
Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction
Published on: October 6, 2022
Cystitis: from urothelial cell biology to clinical applications
Gilho Lee1, Rok Romih2, Daša Zupančič2
1Department of Urology, Dankook University College of Medicine, 359 Manghyang-ro, Cheonan 330-715, Republic of Korea.
Insights
Cystitis, a common bladder disease, often involves urothelial dysfunction and lacks effective treatments. Research is advancing understanding of its mechanisms and developing new therapeutic strategies, including animal models.
Area of Science:
- Urology
- Cell Biology
- Pharmacology
Background:
- Cystitis is a prevalent urinary bladder disease with diverse causes and symptoms, ranging from mild discomfort to severe hemorrhagic forms.
- The chronic or recurrent nature of cystitis, coupled with ineffective treatments, highlights a significant medical and economic burden.
- Urothelial dysfunction is increasingly recognized as a critical factor in the pathogenesis of various cystitis forms.
Purpose of the Study:
- To provide a comprehensive review of urothelial cell biology fundamental to understanding cystitis.
- To discuss various forms of cystitis, current treatment modalities, and recent research advancements.
- To review hemorrhagic cystitis, its association with cyclophosphamide, and management strategies, including relevant animal models.
Main Methods:
- Literature review focusing on urothelial cell biology.
- Analysis of current research on cystitis classification, treatment, and pathogenesis.
- Examination of studies on hemorrhagic cystitis, cyclophosphamide-induced cystitis, and animal models.
Main Results:
- Urothelial dysfunction is central to cystitis development.
- Hemorrhagic cystitis, often induced by cyclophosphamide, requires specific management strategies.
- Cyclophosphamide-induced cystitis animal models offer valuable insights for therapeutic development.
Conclusions:
- A deeper understanding of urothelial biology is essential for effective cystitis treatment.
- Advances in research, particularly utilizing animal models, are crucial for developing novel therapies for cystitis.
- Targeting urothelial dysfunction presents a promising avenue for future cystitis treatment approaches.
Abstract:
Cystitis is a urinary bladder disease with many causes and symptoms. The severity of cystitis ranges from mild lower abdominal discomfort to life-threatening haemorrhagic cystitis. The course of disease is often chronic or recurrent. Although cystitis represents huge economical and medical burden throughout the world and in many cases treatments are ineffective, the mechanisms of its origin and development as well as measures for effective treatment are still poorly understood. However, many studies have demonstrated that urothelial dysfunction plays a crucial role. In the present review we first discuss fundamental issues of urothelial cell biology, which is the core for comprehension of cystitis. Then we focus on many forms of cystitis, its current treatments, and advances in its research. Additionally we review haemorrhagic cystitis with one of the leading causative agents being chemotherapeutic drug cyclophosphamide and summarise its management strategies. At the end we describe an excellent and widely used animal model of cyclophosphamide induced cystitis, which gives researches the opportunity to get a better insight into the mechanisms involved and possibility to develop new therapy approaches.
More Related Videos
Related Concept Videos
01:25Urinary Tract Infection II: Pathophysiology
01:26Urinary Tract Infection I: Introduction
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
01:26Urine Studies II: Urine Culture and Sensitivity Test
01:28Microbiota of the Urogenital Tract